MetaVia Inc. is facing a significant challenge as it received a notice from the Nasdaq Stock Market indicating that it no longer meets the minimum stockholders' equity requirement for continued listing. This situation arises from the company's reported stockholders' equity falling below $2.5 million, as detailed in its recent quarterly filing.
The notice, dated November 17, 2026, highlights that MetaVia's non-compliance with Nasdaq Listing Rule 5550(b)(1) could lead to delisting if not addressed promptly. The company has a 45-day window, until January 4, 2027, to submit a plan to regain compliance.
Background
MetaVia Inc., classified under the SIC code 2834 for Pharmaceutical Preparations, is a smaller reporting company listed on the Nasdaq under the ticker symbol MTVA. The company has undergone several name changes in the past, previously known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc.
What the Filing Says
The SEC filing states, "On November 17, 2026, MetaVia Inc. received written notice from the Nasdaq Stock Market stating that the Company no longer complies with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Capital Market because the Company’s stockholders’ equity... has fallen below $2.5 million." The filing also confirms that the company intends to submit a compliance plan to Nasdaq within the specified timeframe.
Impact
This notice affects MetaVia's stockholders and investors, as the potential delisting could impact their investments and the company's market perception. Other companies in the pharmaceutical sector may also feel the ripple effects, as increased scrutiny on compliance standards could lead to heightened regulatory oversight across the industry.
What's Next
MetaVia intends to submit a compliance plan to Nasdaq by the January 4 deadline. If accepted, the company may receive an extension of up to 180 days to demonstrate compliance with listing standards.
Read Next
Madison Technologies reports Q3 results with net loss
Cyberloq Technologies Releases Q3 Results Amid Challenges
Specificity, Inc. Reports Q3 2026 Financial Results
SUNation Energy reports Q3 2026 financial results
Vystar Corp reports on Q3 performance in latest filing
Alpex Acquisition Corp Reports Quarterly Results










